Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹844 Cr
P/E Ratio
28.39
P/B Ratio
3.39
Industry P/E
36.66
Debt to Equity
0.44
ROE
11.16 %
ROCE
13.57 %
Div. Yield
0 %
Book Value
239.74
EPS
33.63
CFO
₹193.38 Cr
EBITDA
₹386.27 Cr
Net Profit
₹203.27 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Kwality Pharma
| -6.19 | 19.96 | -13.42 | 79.76 | 17.12 | 92.20 | -- |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|
|---|---|---|---|---|---|---|
|
Kwality Pharma
| 113.47 | 5.27 | -58.55 | 1,536.13 | 114.06 | -54.38 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 430.45 | 7,004.90 | 25.53 | 12.5 | |
| 5,218.00 | 8,680.23 | 36.69 | 43.77 | |
| 668.50 | 6,569.59 | 74.41 | 4.01 | |
| 745.45 | 6,001.20 | 34.39 | 20.28 |
No Review & Analysis are available.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Incorporated
1983
Chairman
--
Managing Director
Ramesh Arora
Headquarters
Amritsar, Punjab
Website
Looking for more details about Kwality Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Kwality Pharmaceuticals Ltd stood at ₹ 393 Cr as on 31-Dec-24
The share price of Kwality Pharmaceuticals Ltd is ₹813.15 (BSE) as of 17-Apr-2025 IST. Kwality Pharmaceuticals Ltd has given a return of 17.12% in the last 3 years.
Kwality Pharmaceuticals Ltd has a market capitalisation of ₹ 844 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Kwality Pharmaceuticals Ltd is 3.39 times as on 17-Apr-2025, a 34% discount to its peers’ median range of 5.12 times.
The P/E ratio of Kwality Pharmaceuticals Ltd is 28.39 times as on 17-Apr-2025, a 23% discount to its peers’ median range of 36.66 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Kwality Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Kwality Pharmaceuticals Ltd.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
The prominent promoters of Kwality Pharmaceuticals Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
RAMESH ARORA |
26.01%
|
|
AJAY ARORA |
13.59%
|
|
ADITYA ARORA |
11.95%
|
The chairman of the company is , and the managing director is Ramesh Arora.
There is no promoter pledging in Kwality Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,577
|
|
|
6,871
|
|
|
6,260
|
|
|
5,723
|
| Kwality Pharmaceuticals Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
15
|
|
Operating margin(%)
|
16.41
|
|
Net Margin(%)
|
8.49
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Kwality Pharmaceuticals Ltd was ₹30 Cr.
₹-1.60
(
